NCT05206292Completed
Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders.
Source: ClinicalTrials.gov · Last updated 2 Oct 2026
Brief summary (registry, in English)
Screening for sulfur amino acid metabolism pathologies using a sulfitest in adult patients with psychotic disorder.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 82 (actual)
- First submitted
- 6 Jan 2022
- Start date
- 12 Jan 2023
- Primary completion date
- 17 Jul 2024
- Lead sponsor
- University Hospital, Grenoble
- Diseases
- Schizophrenia
- NCT number
- NCT05206292
What you commit to
- Study type: Interventional
- Participants enrolled: 82
- From 12 Jan 2023 to the primary completion date, 17 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients protected by law (minors, pregnant or breastfeeding women, deprived of liberty or hospitalized under constraint, under administrative or judicial supervision) except patients under tutorship or curatorship.
Who the study is looking for
- Male or female 18 years of age and older,
- Followed for a psychotic disorder,
- With no known organic etiology for the psychotic disorder,
- Not having formulated its opposition to participation in the study (or his/her tutor/curator),
- Affiliated with the social security system.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Grenoble Alpes Coordinator of this site? Confirm its status | Grenoble | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.